Purser et al., 2012 - Google Patents
Regenerative Medicine Manufacturing—A Systems Engineering PerspectivePurser et al., 2012
View PDF- Document ID
- 5904591064636015056
- Author
- Purser M
- Wysk R
- Shirwaiker R
- Harrysson O
- Cohen P
- Jackson J
- Lee S
- Atala A
- Publication year
- Publication venue
- New Directions in Informatics, Optimization, Logistics, and Production
External Links
Snippet
This tutorial introduces the basic concepts associated with a regenerative medicine manufacturing (RMM) system. A background of regenerative medicine, the critical factors involved in its scale-up translation, and an overview of a systems engineering approach for …
- 230000001172 regenerating 0 title abstract description 42
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Naughton | From lab bench to market: critical issues in tissue engineering | |
Hansmann et al. | Bioreactors in tissue engineering—principles, applications and commercial constraints | |
Al-Himdani et al. | Tissue-engineered solutions in plastic and reconstructive surgery: principles and practice | |
Gardel et al. | Use of perfusion bioreactors and large animal models for long bone tissue engineering | |
Horch | Future perspectives in tissue engineering:‘Tissue Engineering’review series | |
JP2017504406A (en) | Tissue graft and method for producing and using the same | |
Govoni et al. | Mechanostimulation protocols for cardiac tissue engineering | |
US11898132B2 (en) | Bioreactor and method of forming complex three-dimensional tissue constructs | |
Matějka et al. | Bioreactor processed stromal cell seeding and cultivation on decellularized pericardium patches for cardiovascular use | |
US10214714B2 (en) | Perfusion bioreactor | |
Purser et al. | Regenerative Medicine Manufacturing—A Systems Engineering Perspective | |
Malik et al. | Organ, Histotypic and Organotypic Culture, and Tissue Engineering | |
CN117530814A (en) | Skeletal organoid construction system and use method thereof | |
WO2016090297A1 (en) | Perfusion bioreactor | |
Mohan et al. | Potential use of 3D CORAGRAF-loaded PDGF-BB in PLGA microsphere seeded mesenchymal stromal cells in enhancing the repair of calvaria critical-size bone defect in rat model | |
Andersson et al. | Regenerative pharmacology: the future is now | |
Hickerson et al. | The next wave: tissue replacement and organ replacement | |
Salazar Ortiz et al. | Migration and remodeling in cartilage replacement materials–an in‐vitro bioreactor study | |
Baran et al. | Tissue engineering: growing replacement human tissue in the lab | |
Maxson et al. | Bioreactors for tissue engineering | |
Schmid | A platform for oxygen-controlled cultivation and investigation of 3-dimensional cell cultures for bone tissue engineering | |
Breuer et al. | Seeding tissue-engineered vascular grafts in a closed, disposable filter-vacuum system | |
Kooistra | Evaluating the Effects of Detergent Concentration on the Reendothelialization and Ultrastructure of Porcine Internal Thoracic Artery Scaffolds | |
Modulevsky et al. | Open Source Biomaterials for Regenerative Medicine | |
Stephenson et al. | Recent advances in tissue engineering strategies for the treatment of joint damage |